BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12406551)

  • 1. Induction of poly(ADP-ribose) polymerase-1 cleavage by antitumor triptycene bisquinones in wild-type and daunorubicin-resistant HL-60 cell lines.
    Wang Y; Perchellet EM; Tamura M; Hua DH; Perchellet JP
    Cancer Lett; 2002 Dec; 188(1-2):73-83. PubMed ID: 12406551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling.
    Perchellet EM; Wang Y; Weber RL; Lou K; Hua DH; Perchellet JP
    Anticancer Drugs; 2004 Nov; 15(10):929-46. PubMed ID: 15514562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Among substituted 9,10-dihydro-9,10-[1,2]benzenoanthracene-1,4,5,8-tetraones, the lead antitumor triptycene bisquinone TT24 blocks nucleoside transport, induces apoptotic DNA fragmentation and decreases the viability of L1210 leukemic cells in the nanomolar range of daunorubicin in vitro.
    Perchellet EM; Sperfslage BJ; Wang Y; Huang X; Tamura M; Hua DH; Perchellet JP
    Anticancer Drugs; 2002 Jul; 13(6):567-81. PubMed ID: 12172502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synthetic triptycene bisquinone, which blocks nucleoside transport and induces DNA fragmentation, retains its cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines.
    Wang B; Wu M; Perchellet EM; McIlvain CJ; Sperfslage BJ; Huang X; Tamura M; Stephany HA; Hua DH; Perchellet JP
    Int J Oncol; 2001 Dec; 19(6):1169-78. PubMed ID: 11713586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
    Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic 1,4-anthracenediones, which block nucleoside transport and induce DNA fragmentation, retain their cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines.
    Wu M; Wang B; Perchellet EM; Sperfslage BJ; Stephany HA; Hua DH; Perchellet JP
    Anticancer Drugs; 2001 Nov; 12(10):807-19. PubMed ID: 11707648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor triptycene bisquinones: a novel synthetic class of dual inhibitors of DNA topoisomerase I and II activities.
    Wang B; Perchellet EM; Wang Y; Tamura M; Hua DH; Perchellet JP
    Anticancer Drugs; 2003 Aug; 14(7):503-14. PubMed ID: 12960734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro.
    Perchellet EM; Magill MJ; Huang X; Brantis CE; Hua DH; Perchellet JP
    Anticancer Drugs; 1999 Sep; 10(8):749-66. PubMed ID: 10573208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor triptycene analogs induce a rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria.
    Wang Y; Perchellet EM; Ward MM; Lou K; Zhao H; Battina SK; Wiredu B; Hua DH; Perchellet JP
    Int J Oncol; 2006 Jan; 28(1):161-72. PubMed ID: 16327993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinone isomers of the WS-5995 antibiotics: synthetic antitumor agents that inhibit macromolecule synthesis, block nucleoside transport, induce DNA fragmentation, and decrease the growth and viability of L1210 leukemic cells more effectively than ellagic acid and genistein in vitro.
    Perchellet EM; Sperfslage BJ; Qabaja G; Jones GB; Perchellet JP
    Anticancer Drugs; 2001 Jun; 12(5):401-17. PubMed ID: 11395569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro.
    Perchellet EM; Magill MJ; Huang X; Dalke DM; Hua DH; Perchellet JP
    Anticancer Drugs; 2000 Jun; 11(5):339-52. PubMed ID: 10912950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
    Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntheses, molecular targets and antitumor activities of novel triptycene bisquinones and 1,4-anthracenedione analogs.
    Hua DH; Lou K; Battina SK; Zhao H; Perchellet EM; Wang Y; Perchellet JP
    Anticancer Agents Med Chem; 2006 Jul; 6(4):303-18. PubMed ID: 16842233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative and proapoptotic activities of pyranoxanthenones, pyranothioxanthenones and their pyrazole-fused derivatives in HL-60 cells.
    Perchellet EM; Ward MM; Skaltsounis AL; Kostakis IK; Pouli N; Marakos P; Perchellet JP
    Anticancer Res; 2006; 26(4B):2791-804. PubMed ID: 16886598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
    Perchellet EM; Sperfslage BJ; McIlvain CJ; Aligiannis N; Pouli N; Marakos P; Skaltsounis AL; Perchellet JP
    Anticancer Res; 2001; 21(6A):3957-67. PubMed ID: 11911277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
    Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
    Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor triptycene analogs directly interact with isolated mitochondria to rapidly trigger markers of permeability transition.
    Perchellet EM; Wang Y; Lou K; Zhao H; Battina SK; Hua DH; Perchellet JP
    Anticancer Res; 2007; 27(5A):3259-71. PubMed ID: 17970069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease activation and cleavage of poly(ADP-ribose) polymerase: an integral part of apoptosis in response to photodynamic treatment.
    He J; Whitacre CM; Xue LY; Berger NA; Oleinick NL
    Cancer Res; 1998 Mar; 58(5):940-6. PubMed ID: 9500454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of anticancer drugs and PJ-34 (poly(ADP-ribose)polymerase-1 (PARP-1) inhibitor) on HL-60 and Jurkat cells.
    Stępnik M; Spryszyńska S; Gorzkiewicz A; Ferlińska M
    Adv Clin Exp Med; 2017; 26(3):379-385. PubMed ID: 28791810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of caspase-3 activation in squamocin-induced apoptosis in leukemia cell line HL-60.
    Zhu XF; Liu ZC; Xie BF; Li ZM; Feng GK; Xie HH; Wu SJ; Yang RZ; Wei XY; Zeng YX
    Life Sci; 2002 Feb; 70(11):1259-69. PubMed ID: 11883704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.